Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome

Objective: The efficacy and safety of definitive chemoradiotherapy (dCRT) for elderly patients with unresectable esophageal cancer (EC) are not yet fully understood. We conducted this study to evaluate the outcome and toxicity in elder patients (65 years and over) of unresectable EC treated with dCRT.

[1]  S. Plumb,et al.  Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study , 2021, The Lancet.

[2]  M. Fakih,et al.  Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial. , 2021, JAMA oncology.

[3]  M. Schäfer,et al.  Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis , 2021, Cancers.

[4]  W. Dale,et al.  How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology , 2020, JCO oncology practice.

[5]  T. Sunkara,et al.  Epidemiology of esophageal cancer: update in global trends, etiology and risk factors , 2020, Clinical Journal of Gastroenterology.

[6]  H. Cai,et al.  Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial , 2020, The oncologist.

[7]  Laura H. Tang,et al.  Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Epstein,et al.  Communication With Older Patients With Cancer Using Geriatric Assessment , 2019, JAMA oncology.

[9]  R. Braren,et al.  Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus , 2018, Radiation oncology.

[10]  H. Cohen,et al.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Sikorska,et al.  Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer , 2017, American journal of clinical oncology.

[12]  Fei Jia,et al.  Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer , 2017, Medicine.

[13]  Mariam Dolidze,et al.  Georgia - Public expenditure review : building a sustainable future , 2017 .

[14]  S. Mohile,et al.  Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Ilson,et al.  Management of localized esophageal cancer in the older patient. , 2014, The oncologist.

[17]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[18]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[19]  M. McCarter,et al.  Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 Hospitals , 2012, Annals of Surgical Oncology.

[20]  Z. Ling,et al.  Epidemiologic risk factors for esophageal cancer development. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[21]  J. Bosset,et al.  Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study. , 2009, Drugs & aging.

[22]  I. Iwanicki-Caron,et al.  Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer , 2008, British Journal of Cancer.

[23]  H. Shimada,et al.  Therapeutic management of elderly patients with esophageal cancer , 2008, Esophagus.

[24]  T. Yano,et al.  A Retrospective Study of Definitive Chemoradiotherapy for Elderly Patients With Esophageal Cancer , 2007, American journal of clinical oncology.

[25]  Lucia M. A. Crane,et al.  Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. , 2007, European journal of cancer.

[26]  M. Bains,et al.  Combined modality chemoradiation in elderly oesophageal cancer patients , 2007, British Journal of Cancer.

[27]  M. Extermann,et al.  Comprehensive geriatric assessment for older patients with cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  G. Launoy,et al.  Trends in the management and survival of digestive tract cancers among patients aged over 80 years , 2005, Alimentary pharmacology & therapeutics.

[30]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[32]  P. Enzinger,et al.  Esophageal cancer. , 2003, The New England journal of medicine.

[33]  G. Noël,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy , 2002 .

[34]  R. Ginsberg,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Y. Nabeya,et al.  Chemoradiation for patients with esophageal cancer aged 80 and older. , 2001, Anticancer research.

[36]  T. Inoue,et al.  A preliminary outcome analysis of the Patterns of Care Study in Japan for esophageal cancer patients with special reference to age: non surgery group. , 2000, International journal of radiation oncology, biology, physics.

[37]  C. Willett,et al.  Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[40]  S. Law.  Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .

[41]  J. Cooper,et al.  Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Cooper,et al.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.